Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q1
- 저널
- CANCER GENE THERAPY20(2) · pp.125 · 2013
- 피인용
- Web of Science 20
- JCR IF
- JCR 2012 2.945
- ISSN
- 0929-1903
저자
- Malilas, W제1저자부산대학교, 대학원, 인지메카트로닉스공학과, KO
- Koh, S. S.과학기술연합대학원대학교, Dept Funct Genom, Korea Res Inst Biosci & Biotechnol, KO
- Srisuttee, R부산대학교, 대학원, 인지메카트로닉스공학과, KO
- Boonying, W부산대학교, 대학원, 인지메카트로닉스공학과, KO
- 조일래부산대학교, 나노과학기술대학, 나노에너지공학과, KO
- Jeong, C-S울산대학교, Sch Biol Sci, KO
- Johnston, R. N.Univ Calgary, Dept Biochem & Mol Biol, Calgary, CN
- 정영화교신저자부산대학교, 나노과학기술대학, 광메카트로닉스공학과, KO
초록
We have recently found a novel oncogene, named cancer upregulated gene 2 (CUG2), which activates Ras and mitogen-activated protein kinases (MAPKs), including ERK, JNK and p38 MAPK. Because activation of these signaling pathways has previously been shown to enhance cancer cell susceptibility to oncolysis by certain viruses, we examined whether vesicular stomatitis virus (VSV) could function as a potential therapeutic agent by efficiently inducing cytolysis in cells transformed by CUG2. Unexpectedly, NIH3T3 cells stably expressing CUG2 (NIH-CUG2) were resistant to VSV because of the activation of signal transducers and activators of transcription 1 (STAT1). The result was supported by evidence showing that suppression of STAT1 with short interference RNA (siRNA) renders cells susceptible to VSV. Furthermore, 2'-5' oligoadenylate synthetase-like (OASL) 2 was the most affected by STAT1 expression level among anti-viral proteins and furthermore suppression of OASL2 mRNA level caused NIH-CUG2 cells to succumb to VSV as seen in NIH-CUG2 cells treated with STAT1 siRNA. In addition, Colon26L5 carcinoma cells stably expressing CUG2 (Colon26L5-CUG2) exhibited resistance to VSV, whereas Colon26L5 stably expressing a control vector yielded to VSV infection. Moreover, Colon26L5-CUG2 cells stably suppressing STAT1 succumbed to VSV infection, resulting in apoptosis. Taken together, we propose that VSV treatment combined with the selective regulation of genes such as STAT1 and OASL2 will improve therapeutic outcomes for CUG2-overexpressing tumors. Cancer Gene Therapy (2013) 20, 125-132; doi:10.1038/cgt.2012.96; published online 11 January 2013
키워드
VSVSTAT1OASL2CUG2virotherapyINTERFERON RESPONSEANTIVIRAL RESPONSEALPHA-INTERFERONSUICIDE GENEWILD-TYPEPATHWAYPROTEINIMMUNITYCELLS
식별자
- WoS UID
- 000315068400010



로그인
연구물 목록으로